These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 15627894
1. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Yazhou C, Wenlv S, Weidong Z, Licun W. Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894 [Abstract] [Full Text] [Related]
2. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R. Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601 [Abstract] [Full Text] [Related]
3. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL. J Clin Pathol; 2003 Apr; 56(4):271-6. PubMed ID: 12663638 [Abstract] [Full Text] [Related]
8. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast. Westhoff CC, Jank P, Jacke CO, Albert US, Ebrahimsade S, Barth PJ, Moll R. Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886 [Abstract] [Full Text] [Related]
11. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Barth PJ, Schenck zu Schweinsberg T, Ramaswamy A, Moll R. Virchows Arch; 2004 Mar; 444(3):231-4. PubMed ID: 14758552 [Abstract] [Full Text] [Related]
13. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Kojc N, Zidar N, Vodopivec B, Gale N. Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177 [Abstract] [Full Text] [Related]
14. Expression of c-kit in common benign and malignant breast lesions. Kondi-Pafiti A, Arkadopoulos N, Gennatas C, Michalaki V, Frangou-Plegmenou M, Chatzipantelis P. Tumori; 2010 Jan; 96(6):978-84. PubMed ID: 21388062 [Abstract] [Full Text] [Related]
20. The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer. Roozdar A, Hayes MM, Pourseyedei B, Zeinalinejad H, Shamsi Meymandi M, Dabiri B, Dabiri S. Arch Iran Med; 2018 May 01; 21(5):185-190. PubMed ID: 29738261 [Abstract] [Full Text] [Related] Page: [Next] [New Search]